Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04204343Completed
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Istanbul University. Primary endpoint: FLACC/VAS Pain Scores up to 48 hours. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04204343.